<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63912">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02097537</url>
  </required_header>
  <id_info>
    <org_study_id>MC1002</org_study_id>
    <nct_id>NCT02097537</nct_id>
  </id_info>
  <brief_title>Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma</brief_title>
  <official_title>Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Santen Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Santen Pharmaceutical Co., Ltd.</source>
  <oversight_info>
    <authority>Japan: Ministry of Health, Labor and Welfare</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Purpose of this study is to evaluate the safety and efficacy of SK-1211 inhalation
      challenge in children with bronchial asthma.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>N/A</study_design>
  <primary_outcome>
    <measure>The rate of subjects whose PC20, the concentration of methacholine that would provoke a fall in FEV1 of 20%, is less than 8mg/mL</measure>
    <time_frame>Visit 1 (Day 1)</time_frame>
    <description>PC20 will be captured once at visit 1</description>
  </primary_outcome>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Methacholine Chloride</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>children with bronchial asthma</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methacholine Chloride (SK-1211)</intervention_name>
    <arm_group_label>Methacholine Chloride</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of bronchial asthma

          -  FEV1/FVC must be 70% or more

          -  &lt;10% decrease in FEV1 in response to inhalation of normal saline

        Exclusion Criteria:

          -  Moderate or severe airflow limitation（FEV1&lt;60% predicted）

          -  Heart attack or stroke in last 3 months

          -  Uncontrolled hypertension, systolic BP&gt;200, or diastolic BP&gt;100

          -  known aortic aneurysm
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Santen study sites</name>
      <address>
        <city>Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Santen Pharmaceutical Co., Ltd.</last_name>
      <phone>+81-6-4802-9341</phone>
      <email>clinical@santen.co.jp</email>
    </contact>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 26, 2014</lastchanged_date>
  <firstreceived_date>March 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Methacholine Chloride</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
